The Role of Autoantibodies in Bone Metabolism and Bone Loss

Area of Science:

• Immunology
• Bone Biology
• Rheumatology

Background:

• Autoimmune diseases frequently involve abnormal bone metabolism, leading to bone loss, deformities, and fractures.
• Antibodies are increasingly recognized for their direct role in modulating bone homeostasis, particularly osteoclast function.
• This impacts patient quality of life through skeletal complications.

Purpose of the Study:

• To explore the direct impact of autoantibodies on bone metabolism in autoimmune conditions.
• To review the role of specific autoantibodies in Rheumatoid Arthritis (RA) and their interaction with bone cells.
• To summarize knowledge on antibodies targeting osteoprotegerin (OPG) in various autoimmune diseases.

Main Methods:

• Review of clinical and pre-clinical studies on autoantibodies and bone metabolism.
• Analysis of autoantibodies associated with Rheumatoid Arthritis (rheumatoid factor, anti-citrullinated protein antibodies, anti-carbamylated protein antibodies).
• Examination of neutralizing antibodies to osteoprotegerin (OPG) in Coeliac Disease, RA, and Spondyloarthritis.

Main Results:

• Autoantibodies in RA, such as rheumatoid factor and anti-citrullinated protein antibodies, interact with bone cells independently of inflammation.
• Neutralizing antibodies to osteoprotegerin (OPG) have been identified in patients with Coeliac Disease, RA, and Spondyloarthritis.
• These findings highlight a direct antibody-mediated mechanism in bone loss associated with autoimmune diseases.

Conclusions:

• Antibodies play a direct role in deranging bone metabolism in autoimmune diseases.
• Understanding these antibody-bone cell interactions is crucial for managing skeletal complications.
• Targeting these pathways may offer new therapeutic strategies for bone loss in autoimmune conditions.